ArticleFrontiers in cardiovascular medicine2026
Predictive factors and clinical outcomes following contemporary percutaneous coronary interventions for chronic total occlusions.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-Term Predictors of Major Adverse Cerebrovascular and Cardiac Events After Successful Transradial Chronic Total Occlusion Recanalization: Five-Year Results of the TRACTOR Study.Journal of personalized medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We aimed to explore the predictive factors and one-year clinical outcomes following contemporary percutaneous coronary intervention for chronic total occlusion lesions (CTO-PCI). Methods: Consecutive patients from January 2018 to December 2020 were enrolled. The primary endpoint was major adverse cardiovascular events (MACE), which included all-cause death and myocardial infarction, while target vessel revascularization (TVR) was defined as the secondary endpoint, all of which were measured at 12 months. Results: 891 consecutive patients underwent 1,010 CTO PCIs. Of these 871 patients meeting the inclusion criteria accepted the index CTO PCI and 96.8% of these cases were available with one-year follow-up data ( Conclusion: Patients deserve acceptable outcomes with a low incidence of adverse events after one year following contemporary CTO PCI. Strategies solving with proximal ambiguity cap and shortening guide-wire manipulation time are conducive to decreasing TVR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.